Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Jake Nichols, PharmD, MBA
Articles
Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits Program
Claudio Faria, PharmD, MPH;Christopher Ciano, RPh;Gary R. Tataronis, MS;Jake Nichols, PharmD, MBA;David Calabrese, RPh, MHP
October 27th 2010Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
Read More
Latest Updated Articles
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Published: August 30th 2024 | Updated: November 21st 2024
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
Published: October 8th 2024 | Updated: November 21st 2024
What Drug Rates Are Reported in Price Transparency Data?
Published: October 7th 2024 | Updated: November 21st 2024
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
